S100A9 and urinary bladder carcinoma: The PPI network analysis of three databases identified the following subsets of DEGs, including CDC20, CDKN2A, CTSV, FOXM1, KRT23, MAGEA6, and S100A9, which were significantly upregulated in bladder cancer.